The case relates to manipulation in the share price of Tijaria Polypipes on its debut in the stock market in 2011.
SAT on October 28, 2013, upheld Sebi's order that barred Grishma Securities, its CEO Mihir Ghelani, Managing Director Ketan Shah and directors Chandrika H Gandhi and Chhabil C Shah from the capital market for five years for fraudulent trading.
In its review plea, Grishma and its executives argued that when the restraint order against its client (Chetan Dave) and other brokers in the matter had been revoked by Sebi, "there was no reason to continue the long-drawn restrain order against appellants (Grishma and its directors)."
"...The grievance of the appellants that in the impugned order there is no rational or justification in distinguishing the case of appellants with other brokers or the case of Chetan Dave cannot be sustained," it added.
More From This Section
Sebi began a probe after noticing a steep fall in the share price of Tijaria Polypipes on the day of its listing on the bourses on October 14, 2011.
The regulator found that Tijaria, through layered transactions, had diverted a part of its initial public offer proceeds to offset losses sustained by certain entities who bought the scrips at a premium to the issue price.